FOXO3 rs1935949: What Your Genotype Means for Longevity
The rs1935949 variant is a single-nucleotide polymorphism located within the FOXO3 gene. It has been studied for its potential association with exceptional human longevity and healthy aging, particularly in female cohorts.
What each genotype means
Associated with longevity potential
This genotype is statistically enriched in cohorts of long-lived individuals, particularly in female populations. Research suggests this variant may offer partial protection against mortality risks associated with aging-related stressors, such as cardiometabolic disease.
The A allele is common, with a minor allele frequency of approximately 0.35 in European populations and 0.45 in East Asian populations.
Potential longevity-associated profile
Carriers of this genotype possess one copy of the allele associated with longevity in various studies. While the association is most pronounced in extreme longevity cohorts, the overall impact on an individual's lifespan remains complex and influenced by environmental factors.
This heterozygous genotype is frequently observed in global populations, reflecting the common distribution of the A and G alleles.
Baseline longevity profile
This genotype represents the more common state in many populations and does not carry the specific enrichment observed in extreme longevity cohorts for this variant. It is important to remember that longevity is a multifactorial trait influenced by a wide array of genetic and lifestyle factors beyond this single marker.
This is a common genotype found across diverse ancestral groups, consistent with the prevalence of the G allele.
Understanding the rs1935949 Variant
The rs1935949 variant is a specific genetic change, or single-nucleotide polymorphism (SNP), located within the FOXO3 gene on chromosome 6. In genetics, an intronic SNP like rs1935949 sits within a non-coding region of the gene, meaning it does not directly alter the sequence of amino acids that make up the resulting protein. Instead, such variants are often investigated for their potential role in regulating how much of a protein is produced or when it is expressed in different tissues. Because this variant is located in a region of the genome that has been heavily studied for its link to human lifespan, researchers use it as a marker to better understand the complex genetic architecture of aging. It is important to note that while this SNP is statistically associated with longevity in some studies, it is considered a marker rather than a direct cause of long life.
The Role of the FOXO3 Gene
The FOXO3 gene encodes the forkhead box O-3 protein, which functions as a transcription factor. This protein acts as a master regulator, controlling the expression of a wide array of genes involved in critical cellular processes, including stress resistance, metabolism, and cell cycle regulation. By influencing these pathways, the FoxO3 protein helps cells respond to environmental stressors, such as oxidative stress or nutrient deprivation. Because of its central role in maintaining cellular homeostasis, FOXO3 is often referred to as a 'resilience gene.' Research suggests that the activity of this gene may help protect against age-related decline by promoting mechanisms that repair cellular damage and reduce the impact of chronic diseases. Consequently, variations in or near this gene are of significant interest to scientists studying why some individuals maintain better health into extreme old age.
Research and Evidence Strength
The evidence linking FOXO3 variants to longevity is considered moderate and context-dependent. While the FOXO3 gene itself is widely recognized as a major longevity-associated locus, the specific effect of rs1935949 has shown variability across different studies. Research has observed that this variant is associated with exceptional longevity, with some data suggesting a more pronounced effect in female cohorts. For instance, certain studies have reported odds ratios indicating a higher likelihood of reaching extreme old age for individuals carrying specific alleles. However, it is crucial to recognize that longevity is a complex, polygenic trait influenced by thousands of genetic variants, as well as environmental and lifestyle factors. The associations observed are statistical in nature and do not imply that carrying a specific genotype guarantees a longer life or protection from disease. Further research is ongoing to clarify the functional mechanisms behind these associations.
Population Frequency and Distribution
Genetic variants like rs1935949 are distributed differently across global populations. Current data indicates that the minor allele frequency for this SNP is approximately 0.35 in European populations and approximately 0.45 in East Asian populations. These frequencies suggest that the variant is relatively common, rather than rare, across these ancestral groups. Because the frequency of the variant varies by ancestry, researchers must account for population stratification when conducting genetic association studies to ensure that findings are robust and not simply a result of shared ancestry within a specific group. Understanding these frequency differences is a standard part of genomic research, helping scientists determine whether a genetic association is consistent across diverse human populations or if it is specific to certain ethnic backgrounds.
Interpreting Your Genetic Information
If you have access to your genetic data, you may see your genotype for rs1935949 listed as C/C, C/T, or T/T. It is important to approach this information with a clear understanding of its limitations. Genetic testing for longevity-associated variants is primarily for educational purposes and does not provide a medical diagnosis or a prediction of your personal lifespan. Because longevity is influenced by a vast array of factors—including diet, physical activity, access to healthcare, and socioeconomic status—a single SNP cannot determine your health outcomes. You cannot 'change' your genotype, but you can focus on evidence-based lifestyle choices that support healthy aging, such as regular exercise, a balanced diet, and routine medical screenings. Always consult with a qualified healthcare professional or a genetic counselor if you have concerns about your health or if you are interested in how your genetic background might relate to your overall wellness.
How common is this variant?
The minor allele frequency for rs1935949 is approximately 0.35 in European populations and 0.45 in East Asian populations.
Frequently asked questions
Does having the 'longevity' genotype mean I will live to 100?
No. Longevity is a complex trait influenced by many genes, environmental factors, and lifestyle choices. A single genetic variant like rs1935949 only provides a small statistical association and cannot predict an individual's lifespan.
Is rs1935949 a diagnostic test for aging?
No, this is not a diagnostic test. Genetic variants associated with longevity are used in research to understand biological pathways, not to diagnose health status or predict future outcomes for individuals.
Can I change my FOXO3 genotype?
No, your genotype is determined at conception and cannot be changed. However, you can influence your healthspan through lifestyle choices like diet, exercise, and regular medical check-ups.
Why do studies show different results for this SNP?
Genetic association studies can vary due to differences in population ancestry, sample sizes, and how 'longevity' is defined. These differences are common in complex trait research and highlight the need for large-scale meta-analyses.
Sources & further reading
Educational information only, last refreshed 9/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1935949?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FOXO3
Well-characterized non-headline FOXO3 variant associated with healthy aging, lower cardiovascular mortality, and survival beyond age 90.
Non-coding FOXO3 variant identified in longitudinal aging studies as conferring an advantage for survival from midlife into advanced old age.
Common upstream intronic regulatory variant in FOXO3 correlated with human longevity and enhanced resilience against metabolic disease.
Functional non-coding variant in the key longevity regulator FOXO3 contributing to extended survival and healthspan.
An intronic variant in the FOXO3 gene consistently associated with human longevity and survival to extreme old age across multiple ethnic cohorts.
Intronic variant in FOXO3 significantly associated with exceptional longevity and survival to advanced old age, showing allele-dependent enhancer activity.
